# Atum

> Atum is a VC fund in Newark backing Biotechnology, Life Science and Therapeutics. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Newark, United States
- Total investments: 2
- Last investment: Oct 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/atum-bio
- X (Twitter): https://twitter.com/atum_bio
- Website: http://www.atum.bio
- Facebook: https://www.facebook.com/atumbio

Atum is a VC fund in Newark focused on Biotechnology and Life Science. ATUM provides tools & solutions for the life sciences, from gene design & synthesis, to protein and antibody services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wheeler Bio | Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. | $31M | Series A | Oct 04, 2022 |  |
| Vernal Biosciences | Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis. | $21M | Series A | Jun 02, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [Alloy Therapeutics](https://shizune.co/investors/profile/alloy-therapeutics) — VC Fund, 2 deals together
- [Charles River Laboratories International](https://shizune.co/investors/profile/charles-river-laboratories-international) — VC Fund, 2 deals together
- [Ampersand Capital Partners](https://shizune.co/investors/profile/ampersand-ventures) — VC Fund, 1 deal together
- [Dynamk Capital](https://shizune.co/investors/profile/dynamk-capital) — VC Fund, 1 deal together
- [Echo Investment Capital](https://shizune.co/investors/profile/echo-investment-capital) — VC Fund, 1 deal together
- [Floating Point Group](https://shizune.co/investors/profile/floating-point-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Atum invest in?

Atum invests primarily in Biotechnology, Life Science and Therapeutics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Atum last invest?

The most recent investment recorded for Atum closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co